Please note that all comments received are considered part of the
public record and made available for public inspection online at http://www.regulations.gov and in the DEA's public docket. Such information
includes personal identifying information (such as your name, address,
etc.) voluntarily submitted by the commenter.
If you want to submit personal identifying information (such as
your name, address, etc.) as part of your comment, but do not want it
to be posted online or made available in the public docket, you must
include the phrase "PERSONAL IDENTIFYING INFORMATION" in the first
paragraph of your comment. You must also place all the personal
identifying information you do not want posted online or made available
in the public docket in the first paragraph of your comment and
identify what information you want redacted.
If you want to submit confidential business information as part of
your comment, but do not want it to be posted online or made available
in the public docket, you must include the phrase "CONFIDENTIAL
BUSINESS INFORMATION" in the first paragraph of your comment. You must
also prominently identify confidential business information to be
redacted within the comment. If a comment has so much confidential
business information that it cannot be effectively redacted, all or
part of that comment may not be posted online or made available in the
public docket.
Personal identifying information and confidential business
information identified and located as set forth above will be redacted,
and the comment, in redacted form, will be posted online and placed in
DEA's public docket file. Please note that the Freedom of Information
Act applies to all comments received. If you wish to inspect the
agency's public docket file in person by appointment, please see the
FOR FURTHER INFORMATION CONTACT paragraph.
DEA implements and enforces Titles II and III of the Comprehensive
Drug Abuse Prevention and Control Act of 1970, often referred to as the
Controlled Substances Act and the Controlled Substances Import and
Export Act (codified at Title 21, Chapter 13 of the U.S.C.), as amended
(hereinafter, "CSA"). DEA drafts and publishes the implementing
regulations for these statutes in Title 21 of the Code of Federal
Regulations (CFR), parts 1300 to 1321. The CSA and its implementing
regulations are designed to prevent, detect, and eliminate the
diversion of controlled substances and listed chemicals into the
illicit market while providing for a sufficient supply of controlled
substances and listed chemicals for legitimate medical, scientific,
research, and industrial purposes. Controlled substances have the
potential for abuse and dependence and are controlled to protect the
public health and safety.
The Deputy Assistant Administrator received applications between
June 12, 2011, and June 30, 2012, requesting exempt chemical
preparation status pursuant to 21 CFR 1308.23. Pursuant to the criteria
stated in 21 U.S.C. 811(g)(3)(B) and in 21 CFR 1308.23, the Deputy
Assistant Administrator has found that each of the compounds, mixtures,
and preparations described in Chart I below is intended for laboratory,
industrial, educational, or special research purposes and not for
general administration to a human being or other animal and either: (1)
Contains no narcotic controlled substance and is packaged in such a
form or concentration that the packaged quantity does not present any
significant potential for abuse; or (2) contains either a narcotic or
non-narcotic controlled substance and one or more adulterating or
denaturing agents in such a manner, combination, quantity, proportion,
or concentration that the preparation or mixture does not present any
potential for abuse; if the preparation or mixture contains a narcotic
controlled substance, it must be formulated in such a manner that it
incorporates methods of denaturing or other means so that the
preparation or mixture is not liable to be abused or have ill effects
if abused, and so that the
narcotic substance cannot in practice be removed.
Chart I |
Supplier |
Product name |
Form |
Exemption
date |
Abbott Laboratories |
ARCHITECT 2nd Generation Testosterone Calibrators (B,C,D,E,F) |
Bottle: 4 mL; Box: 6 bottles |
12/22/2011 |
Abbott Laboratories |
ARCHITECT 2nd Generation Testosterone Controls (L,M,H) |
Bottle: 8 mL; Box: 3 bottles |
12/22/2011 |
Abbott Laboratories |
ARCHITECT Estradiol Assay Diluent, No. 2K25J |
Bag-in-box: 18–200 L; Flask/Carboy: 1–50 L; Bottle/Vial: 0.5 mL–1 L; Box: 1–50 bottles |
12/22/2011 |
Abbott Laboratories |
ARCHITECT Estradiol Assay Diluent, No. 7K72J |
Bottle: 5.9 mL |
12/22/2011 |
Abbott Laboratories |
ARCHITECT Estradiol Reagent Kit, No. 07K72–20 |
Bottle: 5.9 mL; Kit: 16 bottles |
12/22/2011 |
Abbott Laboratories |
ARCHITECT Estradiol Reagent Kit, No. 07K72–25 |
Bottle: 5.9 mL; Kit: 4 bottles |
12/22/2011 |
Abbott Laboratories |
ARCHITECT Estradiol Reagent Kit, No. 2K25–20 |
Bottle: 5.9 mL; Kit: 16 bottles |
12/22/2011 |
Abbott Laboratories |
ARCHITECT Estradiol Reagent Kit, No. 2K25–25 |
Bottle: 5.9 mL; Kit: 4 bottles |
12/22/2011 |
Abbott Laboratories |
AxSYM Estradiol Buffer |
Flask/Carboy: 1–50 L; Bottle/Vial: 0.5 mL–1 L; Box: 1–50 bottles |
12/22/2011 |
Abbott Laboratories |
AxSYM Estradiol Reagent Pack |
Bottle: 5.5 mL, Pack: 4 bottles |
12/22/2011 |
Agilent Technologies |
Special Order Standard TOXI-LAB DISCS; 1, 2, or 3 drugs |
Plastic Vial: 50 discs |
12/22/2011 |
Agilent Technologies |
Special Procedure Standard TOXI-LAB DISCS: Benzodiazepines: Hydrolysis Procedure |
Plastic Vial: 50 discs |
12/22/2011 |
Agilent Technologies |
Special Procedure Standard TOXI-LAB DISCS: Benzoylecgonine |
Plastic Vial: 50 discs |
12/22/2011 |
Agilent Technologies |
Special Procedure Standard TOXI-LAB DISCS: MDMA, MDA, MDEA |
Plastic Vial: 50 discs |
12/22/2011 |
Agilent Technologies |
Special Procedure Standard TOXI-LAB DISCS: Morphine and Hydromorphone: Differentiation |
Plastic Vial: 50 discs |
12/22/2011 |
Agilent Technologies |
Special Procedure Standard TOXI-LAB DISCS: Opiate |
Plastic Vial: 50 discs |
12/22/2011 |
Agilent Technologies |
Special Procedure Standard TOXI-LAB DISCS: Sympathomimetic amines: Differentiation |
Plastic Vial: 50 discs |
12/22/2011 |
Agilent Technologies |
Special Standard TOXI-LAB DISCS LTD-Opiate: 1, 2, or 3 drugs |
Plastic Vial: 50 discs |
12/22/2011 |
Agilent Technologies |
TOXI-LAB Chromatograms A |
Glass jar: 100 Chromatograms |
12/22/2011 |
Agilent Technologies |
TOXI-LAB Chromatograms B |
Glass jar: 100 Chromatograms |
12/22/2011 |
Agilent Technologies |
TOXI-LAB CONTROL LTD FM |
Plastic vial: 50 discs |
12/22/2011 |
Agilent Technologies |
TOXI-LAB CONTROL No. 19 |
Plastic bottle: 2 oz |
12/22/2011 |
Agilent Technologies |
TOXI-LAB CONTROL No. 2 |
Plastic bottle: 2 oz |
12/22/2011 |
Agilent Technologies |
TOXI-LAB CONTROL No. 3 |
Plastic bottle: 2 oz |
12/22/2011 |
Agilent Technologies |
TOXI-LAB CONTROL No. 5 |
Plastic bottle: 2 oz |
12/22/2011 |
Agilent Technologies |
TOXI-LAB CONTROL THC |
Plastic vial: 50 discs |
12/22/2011 |
Agilent Technologies |
TOXI-LAB DISCS A–1 |
Plastic vial: 50 discs |
12/22/2011 |
Agilent Technologies |
TOXI-LAB DISCS A–2 |
Plastic vial: 50 discs |
12/22/2011 |
Agilent Technologies |
TOXI-LAB DISCS A–3 |
Plastic vial: 50 discs |
12/22/2011 |
Agilent Technologies |
TOXI-LAB DISCS A–4 |
Plastic vial: 50 discs |
12/22/2011 |
Agilent Technologies |
TOXI-LAB DISCS B–1 |
Plastic vial: 50 discs |
12/22/2011 |
Agilent Technologies |
TOXI-LAB DISCS B–2 |
Plastic vial: 50 discs |
12/22/2011 |
Agilent Technologies |
TOXI-LAB DISCS B–3 |
Plastic vial: 50 discs |
12/22/2011 |
Agilent Technologies |
TOXI-LAB DISCS B–4 |
Plastic vial: 50 discs |
12/22/2011 |
Agilent Technologies |
TOXI-LAB DISCS LTD HD |
Plastic vial: 50 discs |
12/22/2011 |
Agilent Technologies |
TOXI-LAB DISCS LTD OP |
Plastic vial: 50 discs |
12/22/2011 |
Agilent Technologies |
TOXI-LAB DISCS LTD OPI |
Plastic vial: 50 discs |
12/22/2011 |
Agilent Technologies |
TOXI-LAB DISCS THC |
Plastic vial: 50 discs |
12/22/2011 |
Agilent Technologies |
TOXI-LAB Proficiency Sample |
Plastic bottle: 2 oz |
12/22/2011 |
American Radiolabeled Chemicals, Inc. |
(+)-iodo-Lysergic Acid diethylamide [125I] |
Vial: 1 mL |
12/22/2011 |
American Radiolabeled Chemicals, Inc. |
(+)-Pentazocine (1 mg/mL) |
Vial: 1 mL |
12/22/2011 |
American Radiolabeled Chemicals, Inc. |
(+)-Pentazocine [ring-1,3-3H] |
Vial: 1 mL |
12/22/2011 |
American Radiolabeled Chemicals, Inc. |
(±)-Ketamine [N-methyl-3H] hydrochloride |
Vial: 1 mL |
12/22/2011 |
American Radiolabeled Chemicals, Inc. |
(±)-Ketamine hydrochloride (1 mg/mL) |
Vial: 1 mL |
12/22/2011 |
American Radiolabeled Chemicals, Inc. |
1,1-Dimethyltryptamine (1 mg/mL) |
Vial: 1 mL |
12/22/2011 |
American Radiolabeled Chemicals, Inc. |
1,1-Dimethyltryptamine [a,b-3H] as TFA salt |
Vial: 1 mL |
12/22/2011 |
American Radiolabeled Chemicals, Inc. |
Amobarbital (1 mg/mL) |
Vial: 1 mL |
12/22/2011 |
American Radiolabeled Chemicals, Inc. |
Amphetamine, D-[ring-2,3,5-3H] hydrochloride |
Vial: 1 mL |
12/22/2011 |
American Radiolabeled Chemicals, Inc. |
Amphetamine, DL-[ring-2,3,5-3H] hydrochloride |
Vial: 1 mL |
12/22/2011 |
American Radiolabeled Chemicals, Inc. |
Amphetamine, L-[ring-2,3,5-3H] hydrochloride |
Vial: 1 mL |
12/22/2011 |
American Radiolabeled Chemicals, Inc. |
Buprenorphine [ring-3H] hydrochloride |
Vial: 1 mL |
12/22/2011 |
American Radiolabeled Chemicals, Inc. |
Buprenorphine hydrochloride (1 mg/mL) |
Vial: 1 mL |
12/22/2011 |
American Radiolabeled Chemicals, Inc. |
Cocaine (1 mg/mL) |
Vial: 1 mL |
12/22/2011 |
American Radiolabeled Chemicals, Inc. |
Cocaine [methyl-14C] hydrochloride |
Vial: 1 mL |
12/22/2011 |
American Radiolabeled Chemicals, Inc. |
Cocaine, levo-[benzoyl-3,4-3H(N)] |
Vial: 1 mL |
12/22/2011 |
American Radiolabeled Chemicals, Inc. |
Codeine (1 mg/mL) |
Vial: 1 mL |
12/22/2011 |
American Radiolabeled Chemicals, Inc. |
D-Amphetamine hydrochloride (1 mg/mL) |
Vial: 1 mL |
12/22/2011 |
American Radiolabeled Chemicals, Inc. |
Dextropropoxyphene (1 mg/mL) |
Vial: 1 mL |
12/22/2011 |
American Radiolabeled Chemicals, Inc. |
Diazepam (1 mg/mL) |
Vial: 1 mL |
12/22/2011 |
American Radiolabeled Chemicals, Inc. |
Dihydrocodeine (1 mg/mL) |
Vial: 1 mL |
12/22/2011 |
American Radiolabeled Chemicals, Inc. |
Dihydromorphine (1 mg/mL) |
Vial: 1 mL |
12/22/2011 |
American Radiolabeled Chemicals, Inc. |
Diprenorphine (1 mg/mL) |
Vial: 1 mL |
12/22/2011 |
American Radiolabeled Chemicals, Inc. |
DL-Amphetamine hydrochloride (1 mg/mL) |
Vial: 1 mL |
12/22/2011 |
American Radiolabeled Chemicals, Inc. |
D-Methamphetamine hydrochloride (1 mg/mL) |
Vial: 1 mL |
12/22/2011 |
American Radiolabeled Chemicals, Inc. |
Ecgonine (1 mg/mL) |
Vial: 1 mL |
12/22/2011 |
American Radiolabeled Chemicals, Inc. |
Fentanyl (1 mg/mL) |
Vial: 1 mL |
12/22/2011 |
American Radiolabeled Chemicals, Inc. |
Fentanyl [3H(G)] as TFA salt |
Vial: 1 mL |
12/22/2011 |
American Radiolabeled Chemicals, Inc. |
Fludiazepam (1 mg/mL) |
Vial: 1 mL |
12/22/2011 |
American Radiolabeled Chemicals, Inc. |
Flunitrazepam (1 mg/mL) |
Vial: 1 mL |
12/22/2011 |
American Radiolabeled Chemicals, Inc. |
Flunitrazepam [methyl-3H] |
Vial: 1 mL |
12/22/2011 |
American Radiolabeled Chemicals, Inc. |
Flurazepam (1 mg/mL) |
Vial: 1 mL |
12/22/2011 |
American Radiolabeled Chemicals, Inc. |
Flurazepam [N-methyl-3H] |
Vial: 1 mL |
12/22/2011 |
American Radiolabeled Chemicals, Inc. |
Heroin (1 mg/mL) |
Vial: 1 mL |
12/22/2011 |
American Radiolabeled Chemicals, Inc. |
Heroin [methyl-14C] |
Vial: 1 mL |
12/22/2011 |
American Radiolabeled Chemicals, Inc. |
Heroin [methyl-3H] |
Vial: 1 mL |
12/22/2011 |
American Radiolabeled Chemicals, Inc. |
Hydrocodone (1 mg/mL) |
Vial: 1 mL |
12/22/2011 |
American Radiolabeled Chemicals, Inc. |
Hydromorphone (1 mg/mL) |
Vial: 1 mL |
12/22/2011 |
American Radiolabeled Chemicals, Inc. |
Hydromorphone [N-methyl-14C] hydrochloride |
Vial: 1 mL |
12/22/2011 |
American Radiolabeled Chemicals, Inc. |
Ibogaine (1 mg/mL) |
Vial: 1 mL |
12/22/2011 |
American Radiolabeled Chemicals, Inc. |
L-Amphetamine hydrochloride (1 mg/mL) |
Vial: 1 mL |
12/22/2011 |
American Radiolabeled Chemicals, Inc. |
L-Methamphetamine hydrochloride (1 mg/mL) |
Vial: 1 mL |
12/22/2011 |
American Radiolabeled Chemicals, Inc. |
Lysergic Acid (1 mg/mL) |
Vial: 1 mL |
12/22/2011 |
American Radiolabeled Chemicals, Inc. |
Lysergic acid diethylamide [N-methyl-3H] |
Vial: 1 mL |
3/22/2012 |
American Radiolabeled Chemicals, Inc. |
Mazindol (1 mg/mL) |
Vial: 1 mL |
12/22/2011 |
American Radiolabeled Chemicals, Inc. |
Meperidine Hydrochloride (1 mg/mL) |
Vial: 1 mL |
12/22/2011 |
American Radiolabeled Chemicals, Inc. |
Metazocine (1 mg/mL) |
Vial: 1 mL |
12/22/2011 |
American Radiolabeled Chemicals, Inc. |
Metazocine [ring-1,3-3H] |
Vial: 1 mL |
12/22/2011 |
American Radiolabeled Chemicals, Inc. |
Methamphetamine, D-[methyl-14C] hydrochloride |
Vial: 1 mL |
12/22/2011 |
American Radiolabeled Chemicals, Inc. |
Methamphetamine, L-[methyl-14C] hydrochloride |
Vial: 1 mL |
12/22/2011 |
American Radiolabeled Chemicals, Inc. |
Midazolam (1 mg/mL) |
Vial: 1 mL |
12/22/2011 |
American Radiolabeled Chemicals, Inc. |
Midazolam [3H(G)] |
Vial: 1 mL |
12/22/2011 |
American Radiolabeled Chemicals, Inc. |
Morphine (1 mg/mL) |
Vial: 1 mL |
12/22/2011 |
American Radiolabeled Chemicals, Inc. |
Morphine [N-methyl-14C] |
Vial: 1 mL |
12/22/2011 |
American Radiolabeled Chemicals, Inc. |
Normorphine (1 mg/mL) |
Vial: 1 mL |
12/22/2011 |
American Radiolabeled Chemicals, Inc. |
Oripavine (1 mg/mL) |
Vial: 1 mL |
12/22/2011 |
American Radiolabeled Chemicals, Inc. |
Oxycodone [N-methyl-14C] hydrochloride |
Vial: 1 mL |
12/22/2011 |
American Radiolabeled Chemicals, Inc. |
Oxycodone hydrochloride (1 mg/mL) |
Vial: 1 mL |
12/22/2011 |
American Radiolabeled Chemicals, Inc. |
Oxymorphone (1 mg/mL) |
Vial: 1 mL |
12/22/2011 |
American Radiolabeled Chemicals, Inc. |
Phenazocine (1 mg/mL) |
Vial: 1 mL |
12/22/2011 |
American Radiolabeled Chemicals, Inc. |
Phencyclidine hydrochloride (1 mg/mL) |
Vial: 1 mL |
12/22/2011 |
American Radiolabeled Chemicals, Inc. |
Phenylacetone (1 mg/mL) |
Vial: 1 mL |
12/22/2011 |
American Radiolabeled Chemicals, Inc. |
Tetrahydrocannabidinol (1 mg/mL) |
Vial: 1 mL |
12/22/2011 |
American Radiolabeled Chemicals, Inc. |
Thebaine (1 mg/mL) |
Vial: 1 mL |
12/22/2011 |
American Radiolabeled Chemicals, Inc. |
Thebaine [N-methyl-14C] hydrochloride |
Vial: 1 mL |
12/22/2011 |
American Radiolabeled Chemicals, Inc. |
Thebaine [N-methyl-3H] hydrochloride |
Vial: 1 mL |
12/22/2011 |
American Radiolabeled Chemicals, Inc. |
Thebaine [O-methyl-14C] hydrochloride |
Vial: 1 mL |
12/22/2011 |
American Radiolabeled Chemicals, Inc. |
Thebaine [O-methyl-3H] hydrochloride |
Vial: 1 mL |
12/22/2011 |
American Radiolabeled Chemicals, Inc. |
γ-Hydroxybutyric acid sodium salt (1 mg/mL) |
Vial: 1 mL |
12/22/2011 |
Biochemical Diagnostics, Inc |
Detectabuse Custom Liquid Control Oral Fluid, OF10 |
Glass vials: 1 ml–200 mL |
7/5/2012 |
Biochemical Diagnostics, Inc |
Detectabuse Custom Liquid Control Oral Fluid, OF11 |
Glass vials: 1 ml–200 mL |
7/5/2012 |
Biochemical Diagnostics, Inc |
Detectabuse Custom Liquid Control Oral Fluid, OF12 |
Glass vials: 1 ml–200 mL |
7/5/2012 |
Biochemical Diagnostics, Inc |
Detectabuse Custom Liquid Control Oral Fluid, OF13 |
Glass vials: 1 ml–200 mL |
7/5/2012 |
Biochemical Diagnostics, Inc |
Detectabuse Custom Liquid Control Oral Fluid, OF14 |
Glass vials: 1 ml–200 mL |
7/5/2012 |
Biochemical Diagnostics, Inc |
Detectabuse Custom Liquid Control Oral Fluid, OF15 |
Glass vials: 1 ml–200 mL |
7/5/2012 |
Biochemical Diagnostics, Inc |
Detectabuse Custom Liquid Control Oral Fluid, OF16 |
Glass vials: 1 ml–200 mL |
7/5/2012 |
Biochemical Diagnostics, Inc |
Detectabuse Custom Liquid Control Oral Fluid, OF17 |
Glass vials: 1 ml–200 mL |
7/5/2012 |
Biochemical Diagnostics, Inc |
Detectabuse Custom Liquid Control Oral Fluid, OF18 |
Glass vials: 1 ml–200 mL |
7/5/2012 |
Biochemical Diagnostics, Inc |
Detectabuse Custom Liquid Control Oral Fluid, OF19 |
Glass vials: 1 ml–200 mL |
7/5/2012 |
Biochemical Diagnostics, Inc |
Detectabuse Custom Liquid Control Oral Fluid, OF20 |
Glass vials: 1 ml–200 mL |
7/31/2012 |
Biochemical Diagnostics, Inc |
Detectabuse Custom Liquid Control Oral Fluid, OF21 |
Glass vials: 1 ml–200 mL |
7/31/2012 |
Biochemical Diagnostics, Inc |
Detectabuse Custom Liquid Control Oral Fluid, OF4 |
Glass vials: 1 ml–200 mL |
7/5/2012 |
Biochemical Diagnostics, Inc |
Detectabuse Custom Liquid Control Oral Fluid, OF5 |
Glass vials: 1 ml–200 mL |
7/5/2012 |
Biochemical Diagnostics, Inc |
Detectabuse Custom Liquid Control Oral Fluid, OF6 |
Glass vials: 1 ml–200 mL |
7/5/2012 |
Biochemical Diagnostics, Inc |
Detectabuse Custom Liquid Control Oral Fluid, OF8 |
Glass vials: 1 ml–200 mL |
7/5/2012 |
Biochemical Diagnostics, Inc |
Detectabuse Custom Liquid Control Oral Fluid, OF9 |
Glass vials: 1 ml–200 mL |
7/5/2012 |
Biochemical Diagnostics, Inc |
Detectabuse Custom Liquid Control Urine, MC134 |
Glass vials: 1 ml–200 mL |
11/15/2011 |
Biochemical Diagnostics, Inc |
Detectabuse Custom Liquid Control Urine, MC135 |
Glass vials: 1 ml–200 mL |
11/15/2011 |
Biochemical Diagnostics, Inc |
Detectabuse Custom Liquid Control Urine, MC136 |
Glass vials: 1 ml–100 mL |
11/15/2011 |
Biochemical Diagnostics, Inc |
Detectabuse Custom Liquid Control Urine, MC137 |
Glass vials: 1 ml–200 mL |
11/15/2011 |
Biochemical Diagnostics, Inc |
Detectabuse Custom Liquid Control Urine, MC138 |
Glass vials: 1 ml–200 mL |
11/15/2011 |
Biochemical Diagnostics, Inc |
Detectabuse Custom Liquid Control Urine, MC139 |
Glass vials: 1 ml–200 mL |
11/15/2011 |
Biochemical Diagnostics, Inc |
Detectabuse Custom Liquid Control Urine, MC140 |
Glass vials: 1 ml–200 mL |
11/15/2011 |
Biochemical Diagnostics, Inc |
Detectabuse Custom Liquid Control Urine, MC141 |
Glass vials: 1 ml–200 mL |
11/15/2011 |
Biochemical Diagnostics, Inc |
Detectabuse Custom Liquid Control Urine, MC143 |
Glass vials: 1 ml–200 mL |
2/1/2012 |
Biochemical Diagnostics, Inc |
Detectabuse Custom Liquid Control Urine, MC144 |
Glass vials: 1 ml–200 mL |
3/8/2012 |
Biochemical Diagnostics, Inc |
Detectabuse Custom Liquid Control Urine, MC145 |
Glass vials: 1 ml–200 mL |
3/8/2012 |
Biochemical Diagnostics, Inc |
Detectabuse Custom Liquid Control Urine, MC146 |
Glass vials: 1 ml–200 mL |
3/8/2012 |
Biochemical Diagnostics, Inc |
Detectabuse Custom Liquid Control Urine, MC147 |
Glass vials: 1 ml–200 mL |
3/8/2012 |
Biochemical Diagnostics, Inc |
Detectabuse Custom Liquid Control Urine, MC148 |
Glass vials: 1 ml–200 mL |
3/8/2012 |
Biochemical Diagnostics, Inc |
Detectabuse Custom Liquid Control Urine, MC149 |
Glass vials: 1 ml–200 mL |
3/22/2012 |
Biochemical Diagnostics, Inc |
Detectabuse Custom Liquid Control Urine, MC150 |
Glass vials: 1 ml–200 mL |
7/5/2012 |
Biochemical Diagnostics, Inc |
Detectabuse Custom Liquid Control Urine, MC151 |
Glass vials: 1 ml–200 mL |
8/20/2012 |
Biochemical Diagnostics, Inc |
Detectabuse Custom Liquid Control Urine, MC152 |
Glass vials: 1 ml–200 mL |
8/20/2012 |
Biochemical Diagnostics, Inc |
Detectabuse Custom Liquid Control Urine, MC153 |
Glass vials: 1 ml–200 mL |
8/20/2012 |
Biochemical Diagnostics, Inc |
Detectabuse Custom Liquid Control Urine, MC154 |
Glass vials: 1 ml–200 mL |
8/20/2012 |
Biochemical Diagnostics, Inc |
Detectabuse Custom Liquid Control Urine, MC155 |
Glass vials: 1 ml–200 mL |
8/20/2012 |
Biochemical Diagnostics, Inc |
Detectabuse Custom Liquid Control Urine, MC156 |
Glass vials: 1 ml–200 mL |
8/20/2012 |
Biochemical Diagnostics, Inc |
Detectabuse Custom Liquid Control Urine, MC157 |
Glass vials: 1 ml–200 mL |
8/20/2012 |
Biochemical Diagnostics, Inc |
Detectabuse Custom Liquid Control Urine, MC158 |
Glass vials: 1 ml–200 mL |
8/20/2012 |
Biochemical Diagnostics, Inc |
Detectabuse Custom Liquid Control Urine, MC159 |
Glass vials: 1 ml–200 mL |
8/20/2012 |
Biochemical Diagnostics, Inc |
Detectabuse Custom Liquid Control Urine, MC160 |
Glass vials: 1 ml–200 mL |
8/20/2012 |
Biochemical Diagnostics, Inc |
Detectabuse Custom Liquid Control Urine, MC161 |
Glass vials: 1 ml–200 mL |
8/20/2012 |
Biochemical Diagnostics, Inc |
Detectabuse Custom Liquid Control Urine, MC162 |
Glass vials: 1 ml–200 mL |
8/20/2012 |
Biochemical Diagnostics, Inc |
Detectabuse Custom Liquid Control Urine, MC163 |
Glass vials: 1 ml–200 mL |
8/20/2012 |
Biochemical Diagnostics, Inc |
Detectabuse Custom Liquid Control Urine, MC164 |
Glass vials: 1 ml–200 mL |
8/20/2012 |
Biochemical Diagnostics, Inc |
Detectabuse Custom Liquid Control Urine, MC165 |
Glass vials: 1 ml–200 mL |
8/20/2012 |
Biochemical Diagnostics, Inc |
Detectabuse Custom Liquid Control Urine, MC166 |
Glass vials: 1 ml–200 mL |
8/20/2012 |
Biochemical Diagnostics, Inc |
Detectabuse Custom Liquid Control Urine, MC167 |
Glass vials: 1 ml–200 mL |
8/20/2012 |
Biochemical Diagnostics, Inc |
Detectabuse Custom Liquid Control Urine, MC168 |
Glass vials: 1 ml–200 mL |
8/20/2012 |
Biochemical Diagnostics, Inc |
Detectabuse Custom Liquid Control Urine, MC169 |
Glass vials: 1 ml–200 mL |
8/20/2012 |
Biochemical Diagnostics, Inc |
Detectabuse Custom Liquid Control Urine, MC170 |
Glass vials: 1 ml–200 mL |
8/20/2012 |
Biochemical Diagnostics, Inc |
Detectabuse Custom Liquid Control Urine, MC171 |
Glass vials: 1 ml–200 mL |
7/5/2012 |
Biochemical Diagnostics, Inc |
Detectabuse Custom Liquid Control Urine, MC172 |
Glass vials: 1 ml–200 mL |
7/31/2012 |
Biochemical Diagnostics, Inc |
Detectabuse Custom Liquid Control Urine, MC173 |
Glass vials: 1 ml–200 mL |
7/31/2012 |
Biochemical Diagnostics, Inc |
Detectabuse Custom Liquid Control Urine, SD10 |
Glass vials: 1 ml–200 mL |
2/1/2012 |
Biochemical Diagnostics, Inc |
Detectabuse Custom Liquid Control Urine, SD11 |
Glass vials: 1 ml–200 mL |
2/1/2012 |
Biochemical Diagnostics, Inc |
Detectabuse Custom Liquid Control Urine, SD12 |
Glass vials: 1 ml–200 mL |
2/1/2012 |
Biochemical Diagnostics, Inc |
Detectabuse Custom Liquid Control Urine, SD13 |
Glass vials: 1 ml–200 mL |
2/1/2012 |
Biochemical Diagnostics, Inc |
Detectabuse Custom Liquid Control Urine, SD14 |
Glass vials: 1 ml–200 mL |
2/1/2012 |
Biochemical Diagnostics, Inc |
Detectabuse Custom Liquid Control Urine, SD15 |
Glass vials: 1 ml–200 mL |
7/5/2012 |
Biochemical Diagnostics, Inc |
Detectabuse Custom Liquid Control Urine, SD16 |
Glass vials: 1 ml–200 mL |
7/5/2012 |
Bio-Rad Laboratories |
Liquichek Immunoassay Plus Control Levels 1, 2, and 3 |
Amber Vial: 10 mL; Box: 12 vials |
12/22/2011 |
Bio-Rad Laboratories |
Liquichek Immunoassay Plus Control Trilevel |
Amber Vial: 10 mL; Box: 12 vials |
12/22/2011 |
Bio-Rad Laboratories |
Liquichek Immunoassay Plus Control Trilevel Minipak |
Amber Vial: 5 mL; Box: 3 vials |
12/22/2011 |
Bio-Rad Laboratories |
Liquichek Urine Toxicology Control S10 |
Box: 10 vials, 10 mL each |
5/31/2012 |
Bio-Rad Laboratories |
Liquichek Urine Toxicology Control S10 Low Opiate |
Box: 10 vials, 10 mL each |
5/31/2012 |
Bio-Rad Laboratories |
Liquichek Urine Toxicology Control S10 Low Opiate Minipak |
Amber vial: 10 mL |
5/31/2012 |
Bio-Rad Laboratories |
Liquichek Urine Toxicology Control S10 Minipak |
Amber vial: 10 mL |
5/31/2012 |
Bio-Rad Laboratories |
Liquichek Urine Toxicology Control S20 |
Box: 10 vials, 10 mL each |
5/31/2012 |
Bio-Rad Laboratories |
Liquichek Urine Toxicology Control S20 Low Opiate |
Box: 10 vials, 10 mL each |
5/31/2012 |
Bio-Rad Laboratories |
Liquichek Urine Toxicology Control S20 Low Opiate Minipak |
Amber vial: 10 mL |
5/31/2012 |
Bio-Rad Laboratories |
Liquichek Urine Toxicology Control S20 Minipak |
Amber vial: 10 mL |
5/31/2012 |
Bio-Rad Laboratories |
Liquid Assayed Multiqual Levels 1–3 |
Amber Vial: 2.5 mL; Box: 12 vials |
12/22/2011 |
Bio-Rad Laboratories |
Liquid Assayed Multiqual Trilevel MiniPak |
Amber Vial: 2.5 mL; Box: 3 vials |
12/22/2011 |
Bio-Rad Laboratories |
Liquid Unassayed Multiqual Levels 1–3 |
Amber Vial: 2.5 mL; Box: 12 vials |
12/22/2011 |
Bio-Rad Laboratories |
Liquid Unassayed Multiqual Trilevel MiniPak |
Amber Vial: 2.5 mL; Box: 3 vials |
12/22/2011 |
Bio-Rad Laboratories |
Lyphochek Assayed Chemistry Control Bilevel MiniPak |
Box 2 vials; 5 mL each |
12/22/2011 |
Bio-Rad Laboratories |
Lyphochek Assayed Chemistry Control Levels 1–2 |
Amber Vial: 5 mL; Box: 12 vials |
12/22/2011 |
Bio-Rad Laboratories |
Lyphochek Immunoassay Plus Control Levels 1, 2, and 3 |
Amber Vial: 10 mL; Box: 12 vials |
12/22/2011 |
Bio-Rad Laboratories |
Lyphochek Immunoassay Plus Control Trilevel |
Amber Vial: 10 mL; Box: 12 vials |
12/22/2011 |
Bio-Rad Laboratories |
Lyphochek Immunoassay Plus Control Trilevel Minipak |
Amber Vial: 5 mL; Box: 3 vials |
12/22/2011 |
Bio-Rad Laboratories |
Lyphochek Unassayed Chemistry Control (Human) Bilevel MiniPak |
Box 2 vials; 5 mL each |
12/22/2011 |
Bio-Rad Laboratories |
Lyphochek Unassayed Chemistry Control (Human) Levels 1–2 |
Amber Vial: 5 mL; Box: 25 vials |
12/22/2011 |
Cerilliant Corporation |
(±) Pentazocine-13C3 (0.1 mg/mL) |
Glass Ampule: 2 mL |
12/22/2011 |
Cerilliant Corporation |
(±)-cis-11-Nor-9-carboxy-delta9-THC-D3 glucuronide (0.1 mg/mL) |
Glass Ampule: 2 mL |
12/22/2011 |
Cerilliant Corporation |
3,4-Methylenedioxypyrovalerone HCl (1 mg/mL) |
Glass Ampule: 2 mL |
12/22/2011 |
Cerilliant Corporation |
3,4-Methylenedioxypyrovalerone-D8 HCl (0.1 mg/mL) |
Glass Ampule: 2 mL |
12/22/2011 |
Cerilliant Corporation |
3-Desmethylprodine (1 mg/mL) |
Glass Ampule: 1 mL |
7/31/2012 |
Cerilliant Corporation |
3-Desmethylprodine HCl (1 mg/mL) |
Glass Ampule: 1 mL |
7/31/2012 |
Cerilliant Corporation |
6-alpha/beta-Hydroxyoxymorphone (1 mg/mL) |
Glass Ampule: 2 mL |
12/22/2011 |
Cerilliant Corporation |
6-alpha/beta-Hydroxyoxymorphone-D3 (0.1 mg/mL) |
Glass Ampule: 2 mL |
12/22/2011 |
Cerilliant Corporation |
Buprenorphine N-oxide (1 mg/mL) |
Glass Ampule: 1 mL |
12/22/2011 |
Cerilliant Corporation |
Cannabinol-D3 (0.1 mg/mL) |
Glass Ampule: 2 mL |
12/22/2011 |
Cerilliant Corporation |
Carisoprodol (1 mg/mL) |
Glass Ampule: 2 mL |
12/22/2012 |
Cerilliant Corporation |
Carisoprodol-D7 (0.1 mg/mL) |
Glass Ampule: 2 mL |
12/22/2012 |
Cerilliant Corporation |
Carisoprodol-D7 (1 mg/mL) |
Glass Ampule: 2 mL |
7/31/2012 |
Cerilliant Corporation |
Cocaine N-oxide HCl (1 mg/mL) |
Glass Ampule: 2 mL |
12/22/2011 |
Cerilliant Corporation |
Cocaine N-oxide HCl (1 mg/mL) |
Glass Ampule: 2 mL |
3/8/2012 |
Cerilliant Corporation |
Cocaine N-oxide-D3 HCl (0.1 mg/mL) |
Glass Ampule: 2 mL |
12/22/2011 |
Cerilliant Corporation |
Cocaine N-oxide-D3 HCl (0.1 mg/mL) |
Glass Ampule: 2 mL |
3/8/2012 |
Cerilliant Corporation |
Drug Solution # 15 |
Screw-cap Vial: 50 mL |
6/5/2012 |
Cerilliant Corporation |
Lacosamide (1 mg/mL) |
Glass Ampule: 2 mL |
5/31/2012 |
Cerilliant Corporation |
Lacosamide-13C, D3 (0.1 mg/mL) |
Glass Ampule: 2 mL |
12/22/2011 |
Cerilliant Corporation |
Lacosamide-13C, D3 (1 mg/mL) |
Glass Ampule: 1 mL |
7/31/2012 |
Cerilliant Corporation |
Lisdexamfetamine dimesylate (1 mg/mL) |
Glass Ampule: 2 mL |
12/22/2011 |
Cerilliant Corporation |
Lisdexamfetamine-D4 dimesylate (0.1 mg/mL) |
Glass Ampule: 2 mL |
12/22/2011 |
Cerilliant Corporation |
Mephedrone HCl (1 mg/mL) |
Glass Ampule: 2 mL |
12/22/2011 |
Cerilliant Corporation |
Mephedrone-D3 HCl (0.1 mg/mL) |
Glass Ampule: 2 mL |
12/22/2011 |
Cerilliant Corporation |
Methylone HCl (1 mg/mL) |
Glass Ampule: 2 mL |
12/22/2011 |
Cerilliant Corporation |
Methylone-D3 HCl (0.1 mg/mL) |
Glass Ampule: 2 mL |
12/22/2011 |
Cerilliant Corporation |
Morphine (8 µg/mL) |
Glass Ampule: 2 mL |
12/22/2011 |
Cerilliant Corporation |
Naloxone N-oxide (0.1 mg/mL) |
Glass Ampule: 2 mL |
6/5/2012 |
Cerilliant Corporation |
Norcodeine-D3 (1 mg/mL) |
Glass Ampule: 1 mL |
7/31/2012 |
Cerilliant Corporation |
Normeperidine-D4 (1 mg/mL) |
Glass Ampule: 1 mL |
7/31/2012 |
Cerilliant Corporation |
Noroxycodone and Norhydrocodone Mix (0.5 mg/mL) |
Glass Ampule: 2 mL |
12/22/2011 |
Cerilliant Corporation |
Opiate Internal Standard Mix-15 |
Glass Ampule: 2 mL |
12/22/2011 |
Cerilliant Corporation |
Pseudobuprenorphine dihydrochloride (1.0mg/mL) |
Glass Ampule: 1 mL |
2/1/2012 |
Cerilliant Corporation |
Pyrovalerone HCl (1 mg/mL) |
Glass Ampule: 2 mL |
12/22/2011 |
Cerilliant Corporation |
Secobarbital-D5 (1 mg/mL) |
Glass Ampule: 1 mL |
7/31/2012 |
Cerilliant Corporation |
Zolpidem-D7 (0.1 mg/mL) |
Glass Ampule: 2 mL |
12/22/2011 |
ElSohly Laboratories, Inc |
ELI Drug Standards Δ9-Tetrahydrocannabinolglucoronide (10 µg/mL in MeOH) |
Glass vial: 1 ml |
5/31/2012 |
ElSohly Laboratories, Inc |
ELI Drug Standards Δ9-Tetrahydrocannabinolglucoronide (100 µg/mL in MeOH) |
Glass vial: 1 ml |
5/31/2012 |
Environmental Resource Associates (ERA) |
Chloral Hydrate, Proficiency Testing Material, Catalog No. 853 |
Glass Ampule: 2 mL |
3/8/2012 |
Environmental Resource Associates (ERA) |
Chloral Hydrate, Reference Material, Catalog No. 676 |
Glass Ampule: 2 mL |
3/8/2012 |
Environmental Resource Associates (ERA) |
Waters Steroid Test Mix, Part No. 07364 |
Glass Ampule: 2 mL |
3/8/2012 |
Immunalysis Corporation |
Methadone Calibrator Levels 1–4 |
Glass vial: 10 mL |
6/19/2012 |
Immunalysis Corporation |
Methadone High Control |
Glass vial: 10 mL |
6/19/2012 |
Immunalysis Corporation |
Methadone Low Control |
Glass vial: 10 mL |
6/19/2012 |
Immunalysis Corporation |
Oral Fluid Cutoff Calibrator Pain Management Prediluted in Extraction Buffer |
Glass vial: 10 mL |
6/19/2012 |
Immunalysis Corporation |
Oral Fluid High Positive Control Pain Management Prediluted in Extration Buffer |
Glass vial: 10 mL |
6/19/2012 |
Immunalysis Corporation |
Oral Fluid Low Positive Control Pain Management Prediluted in Extraction Buffer |
Glass vial: 10 mL |
6/19/2012 |
Immunalysis Corporation |
Zolpidem Calibrator |
Glass vial: 10 mL |
6/19/2012 |
Immunalysis Corporation |
Zolpidem High Control |
Glass vial: 10 mL |
6/19/2012 |
Immunalysis Corporation |
Zolpidem Low Control |
Glass vial: 10 mL |
6/19/2012 |
Insys Therapeutics, Inc. |
(-)-delta9-Tetrahydrocannabinol (1.0 mg/mL) |
Glass Ampule: 1 mL |
5/9/2012 |
Microgenics Corporation |
CEDIA Amphetamine OFT Assay, Catalog Number: 10014947 |
Box: 4 bottles; 65 mL each |
12/22/2011 |
Microgenics Corporation |
CEDIA Cannabinoids OFT Assay, Catalog Number: 10014910 |
Box: 4 bottles; 65 mL each |
12/22/2011 |
Microgenics Corporation |
CEDIA Cocaine OFT Assay, Catalog Number: 10014764 |
Box: 4 bottles; 65 mL each |
12/22/2011 |
Microgenics Corporation |
CEDIA Methamphetamine OFT Assay, Catalog Number: 10014949 |
Box: 4 bottles; 65 mL each |
12/22/2011 |
Microgenics Corporation |
CEDIA Methamphetamine OFT Control Set (Low and High) , Catalog #10014953 |
Vial: 10 mL Box: 2 vials |
12/22/2011 |
Microgenics Corporation |
CEDIA Methamphetamine OFT Cutoff Calibrator, Catalog #10014951 |
Vial: 5 mL Box: 1 vial |
12/22/2011 |
Microgenics Corporation |
CEDIA Methamphetamine OFT High Calibrator, Catalog #10014952 |
Vial: 5 mL Box: 1 vial |
12/22/2011 |
Microgenics Corporation |
CEDIA Multi-Drug OFT Control Set (Low and High), Catalog #10014957 |
Vial: 15 mL Box: 2 vials |
12/22/2011 |
Microgenics Corporation |
CEDIA Multi-Drug OFT Cutoff Calibrator, Catalog #10014955 |
Vial: 10 mL Box: 1 vial |
12/22/2011 |
Microgenics Corporation |
CEDIA Multi-Drug OFT High Calibrator, Catalog #10014956 |
Vial: 10 mL Box: 1 vial |
12/22/2011 |
Microgenics Corporation |
CEDIA Opiate OFT Assay, Catalog Number: 10014873 |
Box: 4 bottles; 65 mL each |
12/22/2011 |
Microgenics Corporation |
CEDIA PCP OFT Assay, Catalog Number: 10014888 |
Box: 4 bottles; 65 mL each |
12/22/2011 |
Microgenics Corporation |
CEDIA THC OFT Control Set (Low and High), Catalog #10014925 |
Vial: 10 mL Box: 2 vials |
12/22/2011 |
Microgenics Corporation |
CEDIA THC OFT Cutoff Calibrator, Catalog #10014923 |
Vial: 5 mL Box: 1 vial |
12/22/2011 |
Microgenics Corporation |
CEDIA THC OFT High Calibrator, Catalog #10014924 |
Vial: 5 mL Box: 1 vial |
12/22/2011 |
Microgenics Corporation |
Thermo Scientific CEDIA Methamphetamine OFT Calibrator 1, Catalog Number: 10016345 |
Vial: 5 mL Box: 1 vial |
7/5/2012 |
Microgenics Corporation |
Thermo Scientific CEDIA Methamphetamine OFT Calibrator 1, Catalog Number: 10016362 |
Vial: 5 mL Box: 1 vial |
7/5/2012 |
Microgenics Corporation |
Thermo Scientific CEDIA Methamphetamine OFT Calibrator 2, Catalog Number: 10016346 |
Vial: 5 mL Box: 1 vial |
7/5/2012 |
Microgenics Corporation |
Thermo Scientific CEDIA Methamphetamine OFT Calibrator 2, Catalog Number: 10016363 |
Vial: 5 mL Box: 1 vial |
7/5/2012 |
Microgenics Corporation |
Thermo Scientific CEDIA Methamphetamine OFT Calibrator 3, Catalog Number: 10016347 |
Vial: 5 mL Box: 1 vial |
7/5/2012 |
Microgenics Corporation |
Thermo Scientific CEDIA Methamphetamine OFT Calibrator 3, Catalog Number: 10016364 |
Vial: 5 mL Box: 1 vial |
7/5/2012 |
Microgenics Corporation |
Thermo Scientific CEDIA Methamphetamine OFT Calibrator 4, Catalog Number: 10016348 |
Vial: 5 mL Box: 1 vial |
7/5/2012 |
Microgenics Corporation |
Thermo Scientific CEDIA Methamphetamine OFT Control Set (Low and High), Catalog Number: 10016349 |
Vial: 10 mL Box: 2 vials |
7/5/2012 |
Microgenics Corporation |
Thermo Scientific CEDIA Methamphetamine OFT Control Set (Low and High), Catalog Number: 10016365 |
Vial: 10 mL Box: 2 vials |
7/5/2012 |
Microgenics Corporation |
Thermo Scientific CEDIA Methamphetamine OFT Control Set (Low and High), Catalog Number: 10016808 |
Vial: 10 mL Box: 2 vials |
7/5/2012 |
Microgenics Corporation |
Thermo Scientific CEDIA Methamphetamine OFT Cutoff Calibrator, Catalog Number: 10016807 |
Vial: 5 mL Box: 1 vial |
7/5/2012 |
Microgenics Corporation |
Thermo Scientific CEDIA Multi-Drug OFT Calibrator 1, Catalog Number: 10016865 |
Vial: 10 mL Box: 1 vial |
7/5/2012 |
Microgenics Corporation |
Thermo Scientific CEDIA Multi-Drug OFT Calibrator 1, Catalog Number: 10016882 |
Vial: 10 mL Box: 1 vial |
7/5/2012 |
Microgenics Corporation |
Thermo Scientific CEDIA Multi-Drug OFT Calibrator 2, Catalog Number: 10016866 |
Vial: 10 mL Box: 1 vial |
7/5/2012 |
Microgenics Corporation |
Thermo Scientific CEDIA Multi-Drug OFT Calibrator 2, Catalog Number: 10016883 |
Vial: 10 mL Box: 1 vial |
7/5/2012 |
Microgenics Corporation |
Thermo Scientific CEDIA Multi-Drug OFT Calibrator 3, Catalog Number: 10016867 |
Vial: 10 mL Box: 1 vial |
7/5/2012 |
Microgenics Corporation |
Thermo Scientific CEDIA Multi-Drug OFT Calibrator 3, Catalog Number: 10016884 |
Vial: 10 mL Box: 1 vial |
7/5/2012 |
Microgenics Corporation |
Thermo Scientific CEDIA Multi-Drug OFT Calibrator 4, Catalog Number: 10016868 |
Vial: 10 mL Box: 1 vial |
7/5/2012 |
Microgenics Corporation |
Thermo Scientific CEDIA Multi-Drug OFT Control Set (Low and High), Catalog Number: 10016869 |
Vial: 15 mL Box: 2 vials |
7/5/2012 |
Microgenics Corporation |
Thermo Scientific CEDIA Multi-Drug OFT Control Set (Low and High), Catalog Number: 10016885 |
Vial: 15 mL Box: 2 vials |
7/5/2012 |
Microgenics Corporation |
Thermo Scientific CEDIA Multi-Drug OFT Control Set (Low and High), Catalog Number: 10016895 |
Vial: 15 mL Box: 2 vials |
7/5/2012 |
Microgenics Corporation |
Thermo Scientific CEDIA Multi-Drug OFT Cutoff Calibrator, Catalog Number: 10016894 |
Vial: 10 mL Box: 1 vial |
7/5/2012 |
Microgenics Corporation |
Thermo Scientific CEDIA THC OFT Calibrator 1 Catalog Number: 10016644 |
Vial: 5 mL Box: 1 vial |
7/5/2012 |
Microgenics Corporation |
Thermo Scientific CEDIA THC OFT Calibrator 1 Catalog Number: 10016700 |
Vial: 5 mL Box: 1 vial |
7/5/2012 |
Microgenics Corporation |
Thermo Scientific CEDIA THC OFT Calibrator 2 Catalog Number: 10016646 |
Vial: 5 mL Box: 1 vial |
7/5/2012 |
Microgenics Corporation |
Thermo Scientific CEDIA THC OFT Calibrator 2 Catalog Number: 10016701 |
Vial: 5 mL Box: 1 vial |
7/5/2012 |
Microgenics Corporation |
Thermo Scientific CEDIA THC OFT Calibrator 3 Catalog Number: 10016647 |
Vial: 5 mL Box: 1 vial |
7/5/2012 |
Microgenics Corporation |
Thermo Scientific CEDIA THC OFT Calibrator 3 Catalog Number: 10016702 |
Vial: 5 mL Box: 1 vial |
7/5/2012 |
Microgenics Corporation |
Thermo Scientific CEDIA THC OFT Calibrator 4 Catalog Number: 10016648 |
Vial: 5 mL Box: 1 vial |
7/5/2012 |
Microgenics Corporation |
Thermo Scientific CEDIA THC OFT Control Set (Low and High), Catalog Number: 10016649 |
Vial: 10 mL Box: 2 vials |
7/5/2012 |
Microgenics Corporation |
Thermo Scientific CEDIA THC OFT Control Set (Low and High), Catalog Number: 10016703 |
Vial: 10 mL Box: 2 vials |
7/5/2012 |
Microgenics Corporation |
Thermo Scientific CEDIA THC OFT Control Set (Low and High), Catalog Number: 10016731 |
Vial: 10 mL Box: 2 vials |
7/5/2012 |
Microgenics Corporation |
Thermo Scientific CEDIA THC OFT Cutoff Calibrator Catalog Number: 10016730 |
Vial: 5 mL Box: 1 vial |
7/5/2012 |
Microgenics Corporation |
Thermo Scientific DRI Fentanyl Assay Catalog Number: 10016005 |
Vials: 500 mL |
5/31/2012 |
Microgenics Corporation |
Thermo Scientific DRI Fentanyl Assay Catalog Number: 10016006 |
3 vials, 18 mL each |
5/31/2012 |
Microgenics Corporation |
Thermo Scientific DRI Fentanyl Assay Catalog Number: 10016437 |
3 vials, 18 mL each |
5/31/2012 |
Microgenics Corporation |
Thermo Scientific DRI Fentanyl Calibrator 2 ng/mL Catalog Number: 10016023 |
Vials: 10 mL |
5/31/2012 |
Microgenics Corporation |
Thermo Scientific DRI Fentanyl High Control 1 ng/mL Catalog Number: 10016484 |
Box: 1 vial; 25 mL |
5/31/2012 |
Microgenics Corporation |
Thermo Scientific DRI Fentanyl High Control 2 ng/mL Catalog Number: 10016485 |
Box: 1 vial; 10 mL |
5/31/2012 |
Microgenics Corporation |
Thermo Scientific DRI Fentanyl High Control 3 ng/mL Catalog Number: 10016024 |
Vials: 25 mL |
5/31/2012 |
Microgenics Corporation |
Thermo Scientific DRI Fentanyl High Control 3 ng/mL Catalog Number: 10016486 |
Box: 1 vial; 25 mL |
5/31/2012 |
Microgenics Corporation |
Thermo Scientific DRI Fentanyl Low Control 1 ng/mL Catalog Number: 10016022 |
Vials: 25 mL |
5/31/2012 |
Microgenics Corporation |
Thermo Scientific MAS Omni•CORE Liquid Assayed Integrated Chemistry Control Levels 1–3 |
Vial 5 mL; Box: 6 vials |
12/22/2011 |
Microgenics Corporation |
Thermo Scientific MAS Omni•CORE Liquid Assayed Integrated Chemistry Control Sample Pack |
Box: 6 vials; 5 mL each |
12/22/2011 |
Microgenics Corporation |
Thermo Scientific MAS Omni•IMMUNE Liquid Assayed Integrated Chemistry Control Levels 1–3 |
Vial 5 mL; Box: 6 vials |
12/22/2011 |
Microgenics Corporation |
Thermo Scientific MAS Omni•IMMUNE Liquid Assayed Integrated Chemistry Control Sample Pack |
Box: 6 vials; 5 mL each |
12/22/2011 |
Microgenics Corporation |
Thermo Scientific MAS Omni•IMMUNE PRO Liquid Assayed Integrated Chemistry Control Levels 1–3 |
Vial 5 mL; Box: 6 vials |
12/22/2011 |
Microgenics Corporation |
Thermo Scientific MAS Omni•IMMUNE PRO Liquid Assayed Integrated Chemistry Control Sample Pack |
Box: 6 vials; 5 mL each |
12/22/2011 |
Restek Corporation |
Appendix IX Mix #1, Revised |
Ampule: 2 mL |
12/22/2011 |
Restek Corporation |
Custom a,a-Dimethylphenethylamine Standard |
Ampule: 2 mL |
12/22/2011 |
Restek Corporation |
Custom Chloral Hydrate Standard |
Ampule: 2 mL |
12/22/2011 |
Restek Corporation |
Custom LS4434 Standard 1 |
Ampule: 2 mL |
7/5/2012 |
Restek Corporation |
Metabolomic Standard Mix #1 |
Ampule: 2 mL |
2/1/2012 |
Restek Corporation |
UCMR3 Method 539 Calibration Standard |
Ampule: 2 mL |
12/22/2011 |
Restek Corporation |
UCMR3 Method Calibration Standard |
Ampule: 2 mL |
5/31/2012 |
Roche Diagnostics Operations, Inc |
Oral Fluid DAT Cal A Levels 1–5 |
Glass vial: 5 mL |
7/31/2012 |
Roche Diagnostics Operations, Inc |
Oral Fluid DAT Cal B Levels 1–5 |
Glass vial: 5 mL |
7/31/2012 |
Roche Diagnostics Operations, Inc |
Oral Fluid DAT Control Set A Material No. 05473390190 |
Box of 6 vials, 10 mL each |
7/31/2012 |
Roche Diagnostics Operations, Inc |
Oral Fluid DAT Control Set B Material No. 05473411190 |
Box of 6 vials, 10 mL each |
7/31/2012 |
Roche Diagnostics Operations, Inc |
Oral Fluid DAT Qual Cal Material No. 05475929190 |
Box of 4 vials, 5 mL each |
7/31/2012 |
Roche Diagnostics Operations, Inc |
Oral Fluid DAT SQ Cal A Material No. 05475872190 |
Box of 6 vials, 5 mL each |
7/31/2012 |
Roche Diagnostics Operations, Inc |
Oral Fluid DAT SQ Cal B Material No. 05475899190 |
Box of 6 vials, 5 mL each |
7/31/2012 |
SAFC Biosciences |
HH–4 Cell Culture Medium |
Bag: 1L, 200L, 500L; Bottle: 1L, 2L |
2/3/2012 |
SAFC Biosciences |
HH–4 Cell Culture Medium |
Bag: 20 L, 100L, 1,000 L |
3/22/2012 |
Siemens Healthcare Diagnostics Inc |
ADVIA Chemistry Drug CAL 1 |
Carton: 10 vials; 3 ml each |
11/5/2012 |
Siemens Healthcare Diagnostics Inc |
ADVIA Chemistry Drug CAL 1, Level 2 |
Vial: 3 mL |
11/5/2012 |
Siemens Healthcare Diagnostics Inc |
ADVIA Chemistry Drug CAL 1, Level 3 |
Vial: 3 mL |
11/5/2012 |
Siemens Healthcare Diagnostics Inc |
ADVIA Chemistry Drug CAL 1, Level 4 |
Vial: 3 mL |
11/5/2012 |
Siemens Healthcare Diagnostics Inc |
ADVIA Chemistry Drug CAL 1, Level 5 |
Vial: 3 mL |
11/5/2012 |
Siemens Healthcare Diagnostics Inc |
Bulk EII Plus THC CAL 2 ML |
Bulk Container: 4 mL–100 L |
12/22/2011 |
Siemens Healthcare Diagnostics Inc |
Bulk EII Plus THC CAL 3 ML |
Bulk Container: 4 mL–100 L |
12/22/2011 |
Siemens Healthcare Diagnostics Inc |
Bulk EII Plus THC CAL 4 ML |
Bulk Container: 4 mL–100 L |
12/22/2011 |
Siemens Healthcare Diagnostics Inc |
Bulk EII Plus THC CAL 5 ML |
Bulk Container: 4 mL–100 L |
12/22/2011 |
Siemens Healthcare Diagnostics Inc |
Bulk EII Plus THC Control 1 ML |
Bulk Container: 4 mL–100 L |
12/22/2011 |
Siemens Healthcare Diagnostics Inc |
Bulk EII Plus THC Control 2 ML |
Bulk Container: 4 mL–100 L |
12/22/2011 |
Siemens Healthcare Diagnostics Inc |
Bulk EII Plus THC Control 3 ML |
Bulk Container: 4 mL–100 L |
12/22/2011 |
Siemens Healthcare Diagnostics Inc |
Bulk EII Plus THC Control 4 ML |
Bulk Container: 4 mL–100 L |
12/22/2011 |
Siemens Healthcare Diagnostics Inc |
Bulk EII Plus THC Control 5 ML |
Bulk Container: 4 mL–100 L |
12/22/2011 |
Siemens Healthcare Diagnostics Inc |
Bulk EII Plus THC Control 6 ML |
Bulk Container: 4 mL–100 L |
12/22/2011 |
Siemens Healthcare Diagnostics Inc |
Dimension Drug Calibrator, Level 2 |
Vial: 2.5 mL |
11/5/2012 |
Siemens Healthcare Diagnostics Inc |
Dimension Drug Calibrator, Level 3 |
Vial: 2.5 mL |
11/5/2012 |
Siemens Healthcare Diagnostics Inc |
Dimension Drug Calibrator, Level 4 |
Vial: 2.5 mL |
11/5/2012 |
Siemens Healthcare Diagnostics Inc |
Dimension Drug Calibrator, Level 5 |
Vial: 2.5 mL |
11/5/2012 |
Siemens Healthcare Diagnostics Inc |
Dimension Clinical Chemistry System DRUG Calibrator |
Carton: 10 vials; 2.5 ml each |
11/5/2012 |
Siemens Healthcare Diagnostics Inc |
Dimension Vista DRUG 1 CAL, B |
Vial: 2.5 mL |
7/31/2012 |
Siemens Healthcare Diagnostics Inc |
Dimension Vista Drug 4 CAL, Level B |
Vial: 3 mL |
11/5/2012 |
Siemens Healthcare Diagnostics Inc |
Dimension Vista Drug 4 CAL, Level C |
Vial: 3 mL |
11/5/2012 |
Siemens Healthcare Diagnostics Inc |
Dimension Vista Drug 4 CAL, Level D |
Vial: 3 mL |
11/5/2012 |
Siemens Healthcare Diagnostics Inc |
Dimension Vista Drug 4 CAL, Level E |
Vial: 3 mL |
11/5/2012 |
Siemens Healthcare Diagnostics Inc |
Dimension Vista LOCI 8 CAL |
Box of 10 vials; Vial: 2.5 mL |
3/22/2012 |
Siemens Healthcare Diagnostics Inc |
Dimension Vista LOCI 9 CAL Levels A–E |
Vial: 1.5 mL |
12/22/2011 |
Siemens Healthcare Diagnostics Inc |
Dimension Vista System DRUG 1 CAL |
Carton: 6 vials; 2.5 mL each |
7/31/2012 |
Siemens Healthcare Diagnostics Inc |
Dimension Vista System Drug 4 CAL |
Carton: 10 vials; 3 ml each |
11/5/2012 |
Siemens Healthcare Diagnostics Inc |
Dimension Vista System LOCI 9 Calibrator |
Box of 10 vials; Vial: 1.5 mL |
12/22/2011 |
Siemens Healthcare Diagnostics Inc |
Dimension Vista UDAT CAL |
Glass vial: 3 mL; Carton: 6 vials |
12/22/2011 |
Siemens Healthcare Diagnostics Inc |
Dimension Vista UDAT CAL Bulk, Level B |
Bulk Container: 20 L–25 L |
5/31/2012 |
Siemens Healthcare Diagnostics Inc |
Dimension Vista UDAT CAL Pilot, Level B |
Pilot Container: 2 mL–125 mL |
5/31/2012 |
Siemens Healthcare Diagnostics Inc |
Dimension Vista UDAT CAL, Level B |
Glass vial: 3 mL |
12/22/2011 |
Siemens Healthcare Diagnostics Inc |
FC EII Plus THC CAL 2 ML |
Plastic vial: 15 mL |
12/22/2011 |
Siemens Healthcare Diagnostics Inc |
FC EII Plus THC CAL 3 ML |
Plastic vial: 15 mL |
12/22/2011 |
Siemens Healthcare Diagnostics Inc |
FC EII Plus THC CAL 4 ML |
Plastic vial: 15 mL |
12/22/2011 |
Siemens Healthcare Diagnostics Inc |
FC EII Plus THC CAL 5 ML |
Plastic vial: 15 mL |
12/22/2011 |
Siemens Healthcare Diagnostics Inc |
FC EII Plus THC Control 1 ML |
Plastic vial: 15 mL |
12/22/2011 |
Siemens Healthcare Diagnostics Inc |
FC EII Plus THC Control 2 ML |
Plastic vial: 15 mL |
12/22/2011 |
Siemens Healthcare Diagnostics Inc |
FC EII Plus THC Control 3 ML |
Plastic vial: 15 mL |
12/22/2011 |
Siemens Healthcare Diagnostics Inc |
FC EII Plus THC Control 4 ML |
Plastic vial: 15 mL |
12/22/2011 |
Siemens Healthcare Diagnostics Inc |
FC EII Plus THC Control 5 ML |
Plastic vial: 15 mL |
12/22/2011 |
Siemens Healthcare Diagnostics Inc |
FC EII Plus THC Control 6 ML |
Plastic vial: 15 mL |
12/22/2011 |
Siemens Healthcare Diagnostics Inc |
MP LOCI 9 TTST Cal Lvl 1–7 FC |
Vial: 1–5 mL |
12/22/2011 |
Siemens Healthcare Diagnostics Inc |
MP LOCI 9 TTST Lvl 1–7 Bulk |
Bulk container: 4 mL–100 L |
12/22/2011 |
Siemens Healthcare Diagnostics Inc |
VS Drug 1 Cal Bulk Soln, Level B |
Bulk container: 2 mL–1 L |
7/31/2012 |
Siemens Healthcare Diagnostics Inc |
VS LOCI 9 CAL BULK SOLN Levels 1–5 |
Bulk container: 4 mL–100 L |
12/22/2011 |
Siemens Healthcare Diagnostics Inc |
VS LOCI CAL 8 BULK SOLN Level 2 |
Bulk container: 4 mL–100 L |
3/22/2012 |
Siemens Healthcare Diagnostics Inc |
VS LOCI CAL 8 BULK SOLN Level 3 |
Bulk container: 4 mL–100 L |
3/22/2012 |
Siemens Healthcare Diagnostics Inc |
VS LOCI CAL 8 BULK SOLN Level 4 |
Bulk container: 4 mL–100 L |
3/22/2012 |
Siemens Healthcare Diagnostics Inc |
VS LOCI CAL 8 BULK SOLN Level 5 |
Bulk container: 4 mL–100 L |
3/22/2012 |
Siemens Healthcare Diagnostics Inc |
VS LOCI CAL 8 Vial Level E |
Vial: 2.5 mL |
3/22/2012 |
Siemens Healthcare Diagnostics Inc |
VS LOCI CAL 8 Vial Level B |
Vial: 2.5 mL |
3/22/2012 |
Siemens Healthcare Diagnostics Inc |
VS LOCI CAL 8 Vial Level C |
Vial: 2.5 mL |
3/22/2012 |
Siemens Healthcare Diagnostics Inc |
VS LOCI CAL 8 Vial Level D |
Vial: 2.5 mL |
3/22/2012 |
Supelco, Inc |
Custom Mix, 0.2–163.2 µg/mL in methanol |
Glass ampule: 1 mL |
7/31/2012 |
Ultra Scientific, Inc |
DSA Detection Cocaine HCl Standard |
Amber ampule: 1 mL |
12/22/2011 |
Ultra Scientific, Inc |
DSA Detection Cocaine HCl StandardPhenobarbital (625 µg/mL) |
Amber ampule: 1 mL |
12/22/2011 |
Ultra Scientific, Inc |
DSA Detection Cocaine HCl StandardPhenobarbital (6400 µg/mL) |
Amber ampule: 1 mL |
12/22/2011 |
Ultra Scientific, Inc |
GE-Ion Track 100 ng/µL TNT/Cocaine HCl Standard Rev. 1 |
Amber ampule: 10 mL |
12/22/2011 |
Ultra Scientific, Inc |
GE-Ion Track 100 ng/µL TNT/Cocaine HCl Standard Rev. 1 |
Glass bottle: 100 mL |
12/22/2011 |
Ultra Scientific, Inc |
Phenobarbital (625 µg/mL) |
Amber ampule: 1 mL |
5/31/2012 |
Ultra Scientific, Inc |
Phenobarbital (6400 µg/mL) |
Amber ampule: 1 mL |
5/31/2012 |
Ultra Scientific, Inc |
Ultracheck WS Chloral Hydrate Sample |
Glass ampule: 2 mL |
12/22/2011 |
The Deputy Assistant Administrator has found that each of the
compounds, mixtures, and preparations described in Chart II below is
not consistent with the criteria stated in 21 U.S.C. 811(g)(3)(B) and
in 21 CFR 1308.23. Accordingly, the Deputy Assistant Administrator has
determined that the chemical preparations or mixtures generally
described in Chart II below and specifically described in the
application materials received by DEA, are not exempt from application
of the CSA or from application of the CFR, with regard to the requested
exemption pursuant to 21 CFR 1308.23, as of the date listed below that
was provided in the determination letters to the individual requesters.
The exemptions are applicable only to the precise preparation or
mixture described in the application submitted to DEA in the form(s)
listed in this order. Pursuant to 21 CFR 1308.24(h), any change in the
quantitative or qualitative composition of the preparation or mixture
or change in the trade name or other designation of the preparation or
mixture after the date of application requires a new application.
Pursuant to 21 CFR 1308.24(g), DEA may prescribe requirements other
than those set forth in 1308.24(b)-(e) on a case-by-case basis for
materials exempted in bulk quantities. Accordingly, in order to limit
opportunity for diversion from the larger bulk quantities, DEA has
determined that each of the exempted bulk products listed in this order
may only be used in-house and may not be transported to other
facilities.
Additional exempt chemical preparation requests received between
June 12, 2011, and June 30, 2012, and not otherwise referenced in this
order may remain pending until DEA receives additional information
required, pursuant to 21 CFR 1308.23(d), as detailed in separate
correspondence to individual requesters. DEA's order on such requests
will be published in a future Federal Register.
The statutory authority for exempt chemical preparations is based
on the control status of substances contained within a preparation, the
intended administration of a preparation, and the packaged form of a
preparation. DEA conducts a case-by-case analysis of each application
for exemption to determine whether exemption of a preparation from
certain provisions of the CSA is appropriate pursuant to the specified
statutory and regulatory requirements.
Most exempt chemical preparations have remained effective
indefinitely unless the holder of a specific exempt chemical
preparation specifically requested that the exemption be terminated.
The CSA allows for modifications to the controlled substances schedules
to add, remove, or change the schedule of substances thus resulting in
periodic modifications to the control status of various substances. 21
U.S.C. 811(a). Since the CSA was enacted in 1970, DEA has on several
occasions added to, removed from, or modified the schedules of
controlled substances in accordance with the CSA. Such changes may
result in the non-compliance of exempt chemical preparations with
current statutes or regulations if chemical preparations that have
already obtained exempt status contain newly controlled substances. For
example, although an exempt chemical preparation may continue to be
packaged in the same manner as when it was approved, non-controlled
substances in the preparation may become controlled, thus prompting the
need for a new application for exemption of the chemical preparation to
ensure continued compliance. Other preparations that previously
contained no controlled substances may contain newly controlled
substances and thus would require an application for exemption.
DEA reviews applications for chemical preparation exemptions based
on the statutes and regulations that are in place at the time of the
application, including the control status of substances included in the
preparation. DEA must remain vigilant to ensure that exempt chemical
preparations remain consistent with the standards set forth in the CSA
and its implementing regulations. As such, DEA reminds the public that
any chemical preparation, regardless of whether it was previously
exempt, that contains a newly controlled substance will require a new
application for exemption pursuant to 21 U.S.C. 811(g)(3)(B) and 21 CFR
1308.23-1308.24.
Based on inquiries received from industry, DEA is conducting a
comprehensive review of the exempt chemical preparation regulations.
DEA's regulations at 21 CFR 1308.24(a) state that approved chemical
preparations are exempt from certain provisions of both Subchapter I
and Subchapter II of the CSA: "The chemical preparations and mixtures
approved pursuant to 1308.23 are exempt from application of sections
302, 303, 305, 306, 307, 308, 309, 1002, 1003 and 1004 of the Act (21
U.S.C. 822-823, 825-829, 952-954) and 1301.74 of this chapter, to the
extent described in paragraphs (b) to (h) of this section." Pursuant
to its regulations, DEA has provided exemptions from the application of
section 302, 303, 305, 306, 307, 308, 309, 1002, 1003, and 1004 of the
Act (21 U.S.C. 822-823, 825-829, 952-954) and 21 CFR 1301.74 since the
implementation of the regulations in the early 1970s. Until DEA's
analysis of the exemption regulations is complete, DEA will continue to
review and provide exemptions to chemical preparations consistent with
the implementing regulations, when warranted. DEA will publish a future
notice regarding the outcome of DEA's review of its regulations with
respect to the exemption of chemical preparations.
A list of all current exemptions, including those listed in this
order, is available on DEA's Web site at http://www.deadiversion.usdoj.gov/schedules/exempt/exempt_chemlist.pdf. The
dates of applications of all current exemptions are posted for easy
reference.
Dated: January 14, 2013.
[FR Doc. 2013-01133 Filed 1-18-13; 8:45 am]